PULSE BIOSCIENCES, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Pulse Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2023.
  • Pulse Biosciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $305K.
  • Pulse Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $16.4M, a 79.5% decline from 2022.
  • Pulse Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $79.9M, a 27.5% increase from 2021.
  • Pulse Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $62.7M, a 103% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16.4M -$63.6M -79.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $79.9M +$17.3M +27.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $62.7M +$31.8M +103% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $30.9M +$30.8M +37565% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-31
2019 $82K -$45.4M -99.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-31
2018 $45.5M +$10.1M +28.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 $35.4M +$14.5M +69.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $20.9M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.